ATE233759T1 - Verfahren zur herstellung vom (r)-(+)-3- 1-(2-(4- benzoyl-2-(3,4-difluorophenyl)morpholin-2- yl)ethyl)-4-phenylpiperidin-4-yl -1,1- dimethylharnstoff, deren salzen, solvaten und/oder hydraten - Google Patents

Verfahren zur herstellung vom (r)-(+)-3- 1-(2-(4- benzoyl-2-(3,4-difluorophenyl)morpholin-2- yl)ethyl)-4-phenylpiperidin-4-yl -1,1- dimethylharnstoff, deren salzen, solvaten und/oder hydraten

Info

Publication number
ATE233759T1
ATE233759T1 AT99958317T AT99958317T ATE233759T1 AT E233759 T1 ATE233759 T1 AT E233759T1 AT 99958317 T AT99958317 T AT 99958317T AT 99958317 T AT99958317 T AT 99958317T AT E233759 T1 ATE233759 T1 AT E233759T1
Authority
AT
Austria
Prior art keywords
dimethylurea
difluorophenyl
solvates
hydrates
benzoyl
Prior art date
Application number
AT99958317T
Other languages
English (en)
Inventor
Alain Aulombard
Francoise Bernon
Sabrina Bonnefoy
Alain Burgos
Claude Cabos
Eric Lucas
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE233759T1 publication Critical patent/ATE233759T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99958317T 1998-12-23 1999-12-14 Verfahren zur herstellung vom (r)-(+)-3- 1-(2-(4- benzoyl-2-(3,4-difluorophenyl)morpholin-2- yl)ethyl)-4-phenylpiperidin-4-yl -1,1- dimethylharnstoff, deren salzen, solvaten und/oder hydraten ATE233759T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9816410A FR2787790A1 (fr) 1998-12-23 1998-12-23 Procede de preparation du (r)-(+)-3-{1[2-(4-benzoyl-2-(3,4- difluorophenyl)morpholin-2-yl)ethyl]-4-phenylpiperidin-4-yl} -1,1-dimethyluree, de ses sels, solvats et/ou hydrates
PCT/FR1999/003123 WO2000039126A1 (fr) 1998-12-23 1999-12-14 Procede de preparation du (r)- (+)-3-{1-[2- (4-benzoyl-2- (3,4-difluorophenyl)morpholin-2- yl)ethyl]-4-phenylpiperidin-4- yl}-1,1- dimethyluree, de ses sels, solvats et/ou hydrates

Publications (1)

Publication Number Publication Date
ATE233759T1 true ATE233759T1 (de) 2003-03-15

Family

ID=9534476

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99958317T ATE233759T1 (de) 1998-12-23 1999-12-14 Verfahren zur herstellung vom (r)-(+)-3- 1-(2-(4- benzoyl-2-(3,4-difluorophenyl)morpholin-2- yl)ethyl)-4-phenylpiperidin-4-yl -1,1- dimethylharnstoff, deren salzen, solvaten und/oder hydraten

Country Status (14)

Country Link
US (1) US6392039B1 (de)
EP (1) EP1140923B1 (de)
JP (1) JP3388232B2 (de)
CN (1) CN1334813A (de)
AT (1) ATE233759T1 (de)
AU (1) AU1570300A (de)
CA (1) CA2351539A1 (de)
CZ (1) CZ20012281A3 (de)
DE (1) DE69905761D1 (de)
FR (1) FR2787790A1 (de)
HU (1) HUP0201322A2 (de)
PL (1) PL348672A1 (de)
SK (1) SK9082001A3 (de)
WO (1) WO2000039126A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE517622T1 (de) * 2003-10-27 2011-08-15 Merck Sharp & Dohme Salz eines tetrahydropyranylcyclopentyltetrahydropyridopyr diderivats als ccr-2 antagonisten
EP1754701A4 (de) * 2004-02-25 2007-10-03 Sankyo Co Sulfonyloxyderivate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
US5780466A (en) 1995-01-30 1998-07-14 Sanofi Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
FR2729954B1 (fr) 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2738819B1 (fr) 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
CA2351539A1 (en) 2000-07-06
WO2000039126A1 (fr) 2000-07-06
DE69905761D1 (de) 2003-04-10
EP1140923B1 (de) 2003-03-05
FR2787790A3 (fr) 2000-06-30
US6392039B1 (en) 2002-05-21
CN1334813A (zh) 2002-02-06
PL348672A1 (en) 2002-06-03
SK9082001A3 (en) 2001-12-03
JP2002533462A (ja) 2002-10-08
AU1570300A (en) 2000-07-31
FR2787790A1 (fr) 2000-06-30
HUP0201322A2 (hu) 2002-12-28
CZ20012281A3 (cs) 2001-10-17
EP1140923A1 (de) 2001-10-10
JP3388232B2 (ja) 2003-03-17

Similar Documents

Publication Publication Date Title
DE69923500D1 (de) Verfahren zur Herstellung von Fluorkautschukzusammensetzungen
DE59713049D1 (de) Verfahren zur Herstellung von Cyclischen Amin substituierten Phenyl-alkyl-Ketonen
DE59904565D1 (de) Verfahren zur herstellung von monoaryloxy-ansa-metallocenen
DE69826604D1 (de) Verfahren zur fermentativen herstellung von deacylierten cephalosporinen
ATE388135T1 (de) Verfahren zur herstellung von 1,3-substituierte indene und aryl-annellierte azapolycyclische verbindungen
ATE268749T1 (de) Verfahren zur herstellung von iopamidol
DE69131376T2 (de) Verfahren zur Herstellung von doppelt-diffundierten integrierten MOSFET-Zellen
DE69711706D1 (de) Verfahren zur Herstellung von lichthärtbaren Formkörpern
ATE233759T1 (de) Verfahren zur herstellung vom (r)-(+)-3- 1-(2-(4- benzoyl-2-(3,4-difluorophenyl)morpholin-2- yl)ethyl)-4-phenylpiperidin-4-yl -1,1- dimethylharnstoff, deren salzen, solvaten und/oder hydraten
ATE275149T1 (de) Verfahren zur herstellung von taxanderivaten
ATE355296T1 (de) Verfahren zur herstellung von (e,z) 3-(2- aminoethoxyimino)-androstane-6,17-dione und analoge
DE60224884D1 (de) Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
DE69614936T2 (de) d4T polymorphe Form I Verfahren
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE251132T1 (de) Verfahren zur herstellung von s-aryl-l-cystein und derivate
DE50110561D1 (de) Non-metallocene, verfahren zur herstellung von diesen und deren verwendung zur polymerisation von olefinen
DE69709639D1 (de) Verfahren zur herstellung von phenylheterocyclen die als cox-2 inhibitoren verwendet werden können
ATE173259T1 (de) Verfahren zur herstellung von indolizinderivaten
DE69915951D1 (de) Verfahren zur Herstellung von Pyrrolidinderivaten
DE69514512T2 (de) Verfahren zur herstellung von benzopyranderivaten
ATE272621T1 (de) Verfahren zur stereochemisch kontrollierten herstellung isomerenreiner hochsubstituierter azacyclischer verbindungen
DE69016380D1 (de) Verfahren zur Herstellung von molluskiziden 2,4,5-Tribrompyrrol-3-Carbonitrilen.
DE69419312D1 (de) Verfahren zur Herstellung von weissem Kohlenstoff
ATE402182T1 (de) Verfahren zur herstellung von grignardverbindungen
DE59907019D1 (de) Verfahren zur herstellung von 4,4-dimethyl-5 alpha-cholesta-8,14,24-trien-3 beta-ol und zwischenprodukte im verfahren (i)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties